As detailed in its 2011 Strategic Plan, NHGRI has been pursuing a number of activities in genomic medicine implementation. Links to NHGRI's current initiatives are listed below:
A list of significant advances in the realm of genomic medicinefor 2011-2012, compiled by the NHGRI Genomic Medicine Working Group. The list is updated every month.
NHGRI held a series of Genomic Medicine meetings gathering genomics researchers, clinicians, and other experts from over U.S. institutions involved with the implementation of genomic medicine programs. The goal of these meetings includes identifying research gaps and opportunities; sharing approaches to genomic medicine implementation, and facilitating development of an active research community and possible collaborative projects.
PAR-16-209: [grants.nih.gov] Investigator-Initiated Clinical Sequencing Research (R01)
PAR-16-274: [grants.nih.gov] Serious Adverse Drug Reaction Research (R21)
PAR-16-275: [grants.nih.gov] Serious Adverse Drug Reaction Research (R01)
The NHGRI Genomic Medicine Working Group is a subcommittee of the National Advisory Council for Human Genome Research providing guidance to NHGRI on genomic medicine implementation.
Last Updated: June 15, 2017